Login

Lupin Ltd.

₹1933.2

Overview Charts Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Corp. Action Documents
Consolidated
Standalone

Lupin Ltd.

Add Alert
Add Watchlist

₹1933.2

₹1933.2

13.4 (0.7%) - 29 Sep 2025 04:25 PM

About Company

Lupin is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in many markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position in India and the U.S. across multiple therapy areas, including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and women’s health. 

Market Cap. ₹ 88,300 Cr.
52 Week - High/Low ₹ 2,403/1,795
P/E Ratio 16.93
P/B Ratio 3.64
Enterprise Value ₹ 88,696 Cr.
ROE % 17.78
RSI Value 42.48
EMA 50 1967.39
EMA 200 1975.08
Market Cap. ₹ 88,300 Cr.
52 Week - High/Low ₹ 2,403/1,795
P/E Ratio 23.85
P/B Ratio 5.13
Enterprise Value ₹ 87,548 Cr.
ROE % 21.13
RSI Value 42.48
EMA 50 1967.39
EMA 200 1975.08
Add Parameters

Growth

Chart Icon
View Full Chart

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Terms | Privacy | Contact Us
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.